Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-07

Clinical Trial Update: Liposomal Bupivacaine for Post-operative Pain Control in Adolescent Bariatric Patients [Phase 1]

View source ↗

Summary

A completed Phase 1 clinical trial by Virginia Commonwealth University evaluating liposomal bupivacaine for postoperative pain control in adolescent bariatric s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Exparel (liposomal bupivacaine)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Bariatric Surgery Candidate, Post-operative Pain | Phase 1 | Status: COMPLETED